XML 15 R17.htm IDEA: XBRL DOCUMENT v2.3.0.15
Subsequent Events
9 Months Ended
Sep. 30, 2011
Subsequent Events [Abstract] 
SUBSEQUENT EVENTS
12. SUBSEQUENT EVENTS
On November 1, 2011, the Company received written approval from the U.S. Food and Drug Administration of the Company’s MelaFind® Pre-Market Approval application.